• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用维拉帕米进行抗缺血治疗。急性心肌梗死后通过二级预防改善预后]

[Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].

作者信息

Dotzer F, Gromer H

机构信息

Medizinische Abteilung, Krankenhaus München-Perlach.

出版信息

Fortschr Med. 1993 May 20;111(14):245-8.

PMID:8335304
Abstract

Calcium antagonists reduce myocardial oxygen demand and increase the oxygen supply to the myocardium via a coronary dilating effect. For the treatment of silent myocardial ischämia and of stable and instable angina pectoris, studies with verapamil revealed an anti-ischemic efficacy comparable with that of beta blockers and nitrates. Studies of secondary prophylaxis after acute myocardial infarction reveal a cardioprotective effect of verapamil in terms of a reduction in mortality and re-infarction rates. Calcium antagonists have further organ-protective effects such as a reduction of left ventricular wall hypertrophy and a slowing effect on the progression of arteriosclerotic vascular changes.

摘要

钙拮抗剂可降低心肌需氧量,并通过冠状动脉扩张作用增加心肌的氧供应。对于无症状性心肌缺血以及稳定型和不稳定型心绞痛的治疗,使用维拉帕米的研究显示其抗缺血疗效与β受体阻滞剂和硝酸盐相当。急性心肌梗死后二级预防的研究表明,维拉帕米具有心脏保护作用,可降低死亡率和再梗死率。钙拮抗剂还具有进一步的器官保护作用,如减轻左心室壁肥厚以及减缓动脉硬化性血管病变的进展。

相似文献

1
[Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].[用维拉帕米进行抗缺血治疗。急性心肌梗死后通过二级预防改善预后]
Fortschr Med. 1993 May 20;111(14):245-8.
2
[Cardioprotection with drugs. 1: Coronary heart disease].[药物心脏保护作用。1:冠心病]
Fortschr Med. 1990 Jan 30;108(3):40-4.
3
[Antianginal and antiadrenergic therapy in acute coronary syndrome].[急性冠状动脉综合征中的抗心绞痛和抗肾上腺素能治疗]
Acta Med Croatica. 2004;58(2):123-7.
4
[Calcium antagonists and coronary heart disease. An overview].
Wien Med Wochenschr. 1993;143(19-20):500-9.
5
[Silent myocardial ischemia and nitrates].[无症状心肌缺血与硝酸盐类]
Ann Cardiol Angeiol (Paris). 1997 Jul-Sep;46(7):431-40.
6
[Recent progress regarding nitrates and their use in stable and unstable angina pectoris, pre-infarction syndrome and myocardial infarct].[硝酸盐及其在稳定型和不稳定型心绞痛、心肌梗死前综合征和心肌梗死中的应用的最新进展]
Internist (Berl). 1992 Oct;33(10):684-94.
7
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.在降低既往心肌梗死患者心血管事件方面,基于维拉帕米缓释片的治疗策略等同于基于阿替洛尔的治疗策略:一项国际维拉帕米缓释片-群多普利(INVEST)子研究。
Am Heart J. 2008 Aug;156(2):241-7. doi: 10.1016/j.ahj.2008.02.023.
8
[Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].[急性心肌梗死后的治疗措施:经皮冠状动脉腔内血管成形术(PTCA)、手术及药物的差异应用]
Schweiz Med Wochenschr. 1996 Feb 3;126(5):164-76.
9
[Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases].
Anesteziol Reanimatol. 2001 Sep-Oct(5):55-7.
10
[Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].[二氢吡啶类与非二氢吡啶类钙拮抗剂联合应用对合并动脉高血压的冠心病患者的降压及抗缺血作用评估]
Klin Med (Mosk). 2006;84(11):52-6.